VBI Vaccines Inc logo

VBV - VBI Vaccines Inc Share Price

C$4.82 -0.3  -5.1%

Last Trade - 23/03/18

Mid Cap
Market Cap £670.7m
Enterprise Value £586.4m
Revenue £678k
Position in Universe th / 2698
Unlock VBV Revenue
Relative Strength (%)
1m +0.30%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.96 0.55 0.87 3.36 2.22 1.06 3.27 47.7 +2.1%
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, VBIVaccines Inc revenues decreased 27% to $301K. Net lossincreased from $8.4M to $17.6M. Revenues reflect China/HongKong segment decrease of 45% to $128K, Europe segmentdecrease of 92% to $4K. Higher net loss reflects Researchand development - Balancing val increase from $2.9M to$6.4M (expense), General and administration - Balancing vincrease of 66% to $4.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


VBV Revenue Unlock VBV Revenue

Net Income

VBV Net Income Unlock VBV Revenue

Normalised EPS

VBV Normalised EPS Unlock VBV Revenue

PE Ratio Range

VBV PE Ratio Range Unlock VBV Revenue

Dividend Yield Range

VBV Dividend Yield Range Unlock VBV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
VBV EPS Forecasts Unlock VBV Revenue
Profile Summary

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated April 9, 1965
Public Since January 13, 2010
No. of Shareholders: 819
No. of Employees: 127
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Toronto Stock Exchange
Shares in Issue 254,195,435
Free Float (0.0%)
Eligible for
VBV Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for VBV
Upcoming Events for VBV
Frequently Asked Questions for VBI Vaccines Inc
What is the VBI Vaccines Inc share price?

As of 23/03/18, shares in VBI Vaccines Inc are trading at C$4.82, giving the company a market capitalisation of £670.7m. This share price information is delayed by 15 minutes.

How has the VBI Vaccines Inc share price performed this year?

Shares in VBI Vaccines Inc are currently trading at C$4.82 and the price has moved by -29.84% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the VBI Vaccines Inc price has moved by -43.47% over the past year.

What are the analyst and broker recommendations for VBI Vaccines Inc?

Of the analysts with advisory recommendations for VBI Vaccines Inc, there are there are currently 3 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for VBI Vaccines Inc is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will VBI Vaccines Inc next release its financial results?

VBI Vaccines Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the VBI Vaccines Inc dividend yield?

VBI Vaccines Inc does not currently pay a dividend.

Does VBI Vaccines Inc pay a dividend?

VBI Vaccines Inc does not currently pay a dividend.

When does VBI Vaccines Inc next pay dividends?

VBI Vaccines Inc does not currently pay a dividend.

How do I buy VBI Vaccines Inc shares?

To buy shares in VBI Vaccines Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of VBI Vaccines Inc?

Shares in VBI Vaccines Inc are currently trading at C$4.82, giving the company a market capitalisation of £670.7m.

Where are VBI Vaccines Inc shares listed? Where are VBI Vaccines Inc shares listed?

Here are the trading details for VBI Vaccines Inc:

Country of listing: Canada
Exchange: TOR
Ticker Symbol: VBV
What kind of share is VBI Vaccines Inc?

We were not able to load our ranking data for VBI Vaccines Inc

Is there a VBI Vaccines Inc share price forecast 2021?

We were not able to load any forecast data for VBI Vaccines Inc.

How can I tell whether the VBI Vaccines Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VBI Vaccines Inc. Over the past six months, the relative strength of its shares against the market has been -13.62%. At the current price of C$4.82, shares in VBI Vaccines Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the VBI Vaccines Inc PE Ratio?

We were not able to find PE ratio data for VBI Vaccines Inc.

Who are the key directors of VBI Vaccines Inc?

VBI Vaccines Inc's management team is headed by:

Christopher McNulty - CFO
Joanne Cordeiro - IND
Jeffrey Baxter - PRE
Steven Gillis - NEC
David Anderson - CSO
Francisco Diazmitoma - OTH
Nell Beattie - OTH
Avi Mazaltov - GMG
Blaine Mckee - IND
Damian Braga - IND
Linda Bain - DRC
Who are the major shareholders of VBI Vaccines Inc?

Here are the top five shareholders of VBI Vaccines Inc based on the size of their shareholding:

Perceptive Advisors LLC Private Equity
Percentage owned: 21.91% (55.7m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 7.35% (18.7m shares)
ARCH Venture Partners Venture Capital
Percentage owned: 5.12% (13.0m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.04% (12.8m shares)
SPDR S&P Biotech ETF Mutual Fund
Percentage owned: 3.58% (9.10m shares)
Similar to VBV
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.